Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 277


Role of CD8+ T cells in crescentic glomerulonephritis.

Chen A, Lee K, Guan T, He JC, Schlondorff D.

Nephrol Dial Transplant. 2019 Mar 16. pii: gfz043. doi: 10.1093/ndt/gfz043. [Epub ahead of print]


LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β-Induced Angiogenesis.

Hong Q, Zhang L, Fu J, Verghese DA, Chauhan K, Nadkarni GN, Li Z, Ju W, Kretzler M, Cai GY, Chen XM, D'Agati VD, Coca SG, Schlondorff D, He JC, Lee K.

J Am Soc Nephrol. 2019 Apr;30(4):546-562. doi: 10.1681/ASN.2018060599. Epub 2019 Mar 11.


Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease.

Fu J, Akat KM, Sun Z, Zhang W, Schlondorff D, Liu Z, Tuschl T, Lee K, He JC.

J Am Soc Nephrol. 2019 Apr;30(4):533-545. doi: 10.1681/ASN.2018090896. Epub 2019 Mar 7.


Bowman's capsule provides a protective niche for podocytes from cytotoxic CD8+ T cells.

Chen A, Lee K, D'Agati VD, Wei C, Fu J, Guan TJ, He JC, Schlondorff D, Agudo J.

J Clin Invest. 2018 Aug 1;128(8):3413-3424. doi: 10.1172/JCI97879. Epub 2018 Jul 9.


Gene expression profiles of glomerular endothelial cells support their role in the glomerulopathy of diabetic mice.

Fu J, Wei C, Zhang W, Schlondorff D, Wu J, Cai M, He W, Baron MH, Chuang PY, Liu Z, He JC, Lee K.

Kidney Int. 2018 Aug;94(2):326-345. doi: 10.1016/j.kint.2018.02.028. Epub 2018 May 31.


The changing of the guard: the past, the present, and the future of Kidney International.

Schlöndorff D; Entire Editorial Team.

Kidney Int. 2017 Dec;92(6):1296-1298. doi: 10.1016/j.kint.2017.10.003. No abstract available.


Revisiting the determinants of the glomerular filtration barrier: what goes round must come round.

Schlöndorff D, Wyatt CM, Campbell KN.

Kidney Int. 2017 Sep;92(3):533-536. doi: 10.1016/j.kint.2017.06.003.


Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.

Qi H, Casalena G, Shi S, Yu L, Ebefors K, Sun Y, Zhang W, D'Agati V, Schlondorff D, Haraldsson B, Böttinger E, Daehn I.

Diabetes. 2017 Mar;66(3):763-778. doi: 10.2337/db16-0695. Epub 2016 Nov 29.


Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease.

Wyatt CM, Schlondorff D.

Kidney Int. 2016 Apr;89(4):734-7. doi: 10.1016/j.kint.2016.02.009.


Good news and best wishes for 2016 to the global nephrology community from Kidney International.

Schlöndorff D, Radhakrishnan J, Wyatt C, Kasiske B, Harris D.

Kidney Int. 2016 Jan;89(1):2. doi: 10.1016/j.kint.2015.10.005. No abstract available.


BAMBI elimination enhances alternative TGF-β signaling and glomerular dysfunction in diabetic mice.

Fan Y, Li X, Xiao W, Fu J, Harris RC, Lindenmeyer M, Cohen CD, Guillot N, Baron MH, Wang N, Lee K, He JC, Schlondorff D, Chuang PY.

Diabetes. 2015 Jun;64(6):2220-33. doi: 10.2337/db14-1397. Epub 2015 Jan 9.


Putting the glomerulus back together: per aspera ad astra ("a rough road leads to the stars").

Schlöndorff D.

Kidney Int. 2014 May;85(5):991-8. doi: 10.1038/ki.2014.51. No abstract available.


Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro.

Casalena G, Krick S, Daehn I, Yu L, Ju W, Shi S, Tsai SY, D'Agati V, Lindenmeyer M, Cohen CD, Schlondorff D, Bottinger EP.

Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1372-80. doi: 10.1152/ajprenal.00608.2013. Epub 2014 Mar 5.


Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.

Daehn I, Casalena G, Zhang T, Shi S, Fenninger F, Barasch N, Yu L, D'Agati V, Schlondorff D, Kriz W, Haraldsson B, Bottinger EP.

J Clin Invest. 2014 Apr;124(4):1608-21. doi: 10.1172/JCI71195. Epub 2014 Mar 3.


Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?

Schlöndorff D.

Kidney Int. 2014 Mar;85(3):499-501. doi: 10.1038/ki.2013.549.


Kidney international web focus on transplantation.

Coates PT, Ross M, Schlöndorff D.

Kidney Int. 2014 Feb;85(2):227-9. doi: 10.1038/ki.2013.550. No abstract available.


Epithelial cell TGFβ signaling induces acute tubular injury and interstitial inflammation.

Gentle ME, Shi S, Daehn I, Zhang T, Qi H, Yu L, D'Agati VD, Schlondorff DO, Bottinger EP.

J Am Soc Nephrol. 2013 Apr;24(5):787-99. doi: 10.1681/ASN.2012101024. Epub 2013 Mar 28.


Accelerated reendothelialization, increased neovascularization and erythrocyte extravasation after arterial injury in BAMBI-/- mice.

Guillot N, Kollins D, Badimon JJ, Schlondorff D, Hutter R.

PLoS One. 2013;8(3):e58550. doi: 10.1371/journal.pone.0058550. Epub 2013 Mar 1.


Up, up and away….

Schlöndorff D.

Kidney Int. 2013 Jan;83(1):3. doi: 10.1038/ki.2012.377. No abstract available.


BAMBI regulates angiogenesis and endothelial homeostasis through modulation of alternative TGFβ signaling.

Guillot N, Kollins D, Gilbert V, Xavier S, Chen J, Gentle M, Reddy A, Bottinger E, Jiang R, Rastaldi MP, Corbelli A, Schlondorff D.

PLoS One. 2012;7(6):e39406. doi: 10.1371/journal.pone.0039406. Epub 2012 Jun 25.


Now we must work even harder.

Schlöndorff D.

Kidney Int. 2012 Jun;81(11):1049-50. doi: 10.1038/ki.2012.81. No abstract available.


Myeloid cell-derived hypoxia-inducible factor attenuates inflammation in unilateral ureteral obstruction-induced kidney injury.

Kobayashi H, Gilbert V, Liu Q, Kapitsinou PP, Unger TL, Rha J, Rivella S, Schlöndorff D, Haase VH.

J Immunol. 2012 May 15;188(10):5106-15. doi: 10.4049/jimmunol.1103377. Epub 2012 Apr 6.


Activation of innate immune defense mechanisms contributes to polyomavirus BK-associated nephropathy.

Ribeiro A, Wörnle M, Motamedi N, Anders HJ, Gröne EF, Nitschko H, Kurktschiev P, Debiec H, Kretzler M, Cohen CD, Gröne HJ, Schlöndorff D, Schmid H.

Kidney Int. 2012 Jan;81(1):100-11. doi: 10.1038/ki.2011.311. Epub 2011 Sep 14.


BAMBI is expressed in endothelial cells and is regulated by lysosomal/autolysosomal degradation.

Xavier S, Gilbert V, Rastaldi MP, Krick S, Kollins D, Reddy A, Bottinger E, Cohen CD, Schlondorff D.

PLoS One. 2010 Sep 24;5(9):e12995. doi: 10.1371/journal.pone.0012995.


Innate immune receptors and autophagy: implications for autoimmune kidney injury.

Anders HJ, Schlondorff DO.

Kidney Int. 2010 Jul;78(1):29-37. doi: 10.1038/ki.2010.111. Epub 2010 Apr 28. Review.


Choosing the right mouse model for diabetic nephropathy.

Schlöndorff D.

Kidney Int. 2010 May;77(9):749-50. doi: 10.1038/ki.2009.545. No abstract available.


Human nephrosclerosis triggers a hypoxia-related glomerulopathy.

Neusser MA, Lindenmeyer MT, Moll AG, Segerer S, Edenhofer I, Sen K, Stiehl DP, Kretzler M, Gröne HJ, Schlöndorff D, Cohen CD.

Am J Pathol. 2010 Feb;176(2):594-607. doi: 10.2353/ajpath.2010.090268. Epub 2009 Dec 17.


Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves long-term renal allograft outcome.

Dehmel S, Wang S, Schmidt C, Kiss E, Loewe RP, Chilla S, Schlöndorff D, Gröne HJ, Luckow B.

Eur J Immunol. 2010 Jan;40(1):267-78. doi: 10.1002/eji.200939652.


Microinjection of Cre recombinase protein into zygotes enables specific deletion of two eukaryotic selection cassettes and enhances the expression of a DsRed2 reporter gene in Ccr2/Ccr5 double-deficient mice.

Luckow B, Hänggli A, Maier H, Chilla S, Loewe RP, Dehmel S, Schlöndorff D, Loetscher P, Zerwes HG, Müller M.

Genesis. 2009 Aug;47(8):545-58. doi: 10.1002/dvg.20531.


Efficient renal recruitment of macrophages and T cells in mice lacking the duffy antigen/receptor for chemokines.

Vielhauer V, Allam R, Lindenmeyer MT, Cohen CD, Draganovici D, Mandelbaum J, Eltrich N, Nelson PJ, Anders HJ, Pruenster M, Rot A, Schlöndorff D, Segerer S.

Am J Pathol. 2009 Jul;175(1):119-31. doi: 10.2353/ajpath.2009.080590. Epub 2009 Jun 4.


The mesangial cell revisited: no cell is an island.

Schlöndorff D, Banas B.

J Am Soc Nephrol. 2009 Jun;20(6):1179-87. doi: 10.1681/ASN.2008050549. Epub 2009 May 21. Review.


Renal gene and protein expression signatures for prediction of kidney disease progression.

Ju W, Eichinger F, Bitzer M, Oh J, McWeeney S, Berthier CC, Shedden K, Cohen CD, Henger A, Krick S, Kopp JB, Stoeckert CJ Jr, Dikman S, Schröppel B, Thomas DB, Schlondorff D, Kretzler M, Böttinger EP.

Am J Pathol. 2009 Jun;174(6):2073-85. doi: 10.2353/ajpath.2009.080888. Erratum in: Am J Pathol. 2009 Sep;175(3):1349.


Proteinuria and hyperglycemia induce endoplasmic reticulum stress.

Lindenmeyer MT, Rastaldi MP, Ikehata M, Neusser MA, Kretzler M, Cohen CD, Schlöndorff D.

J Am Soc Nephrol. 2008 Nov;19(11):2225-36. doi: 10.1681/ASN.2007121313. Epub 2008 Sep 5.


Overview of factors contributing to the pathophysiology of progressive renal disease.

Schlondorff DO.

Kidney Int. 2008 Oct;74(7):860-6. doi: 10.1038/ki.2008.351. Epub 2008 Jul 23. Review.


Compartment specific expression of dendritic cell markers in human glomerulonephritis.

Segerer S, Heller F, Lindenmeyer MT, Schmid H, Cohen CD, Draganovici D, Mandelbaum J, Nelson PJ, Gröne HJ, Gröne EF, Figel AM, Nössner E, Schlöndorff D.

Kidney Int. 2008 Jul;74(1):37-46. doi: 10.1038/ki.2008.99. Epub 2008 Mar 26.


B cells and tertiary lymphoid organs in renal inflammation.

Segerer S, Schlöndorff D.

Kidney Int. 2008 Mar;73(5):533-7. Epub 2007 Dec 19. Review.


Role of chemokines for the localization of leukocyte subsets in the kidney.

Segerer S, Schlöndorff D.

Semin Nephrol. 2007 May;27(3):260-74. Review.


Different roles of TiR8/Sigirr on toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells.

Lech M, Garlanda C, Mantovani A, Kirschning CJ, Schlöndorff D, Anders HJ.

Kidney Int. 2007 Jul;72(2):182-92. Epub 2007 May 2.


Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

Lindenmeyer MT, Kretzler M, Boucherot A, Berra S, Yasuda Y, Henger A, Eichinger F, Gaiser S, Schmid H, Rastaldi MP, Schrier RW, Schlöndorff D, Cohen CD.

J Am Soc Nephrol. 2007 Jun;18(6):1765-76. Epub 2007 May 2.


Toll-like receptors: emerging concepts in kidney disease.

Anders HJ, Schlöndorff D.

Curr Opin Nephrol Hypertens. 2007 May;16(3):177-83. Review.


The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.

Ninichuk V, Khandoga AG, Segerer S, Loetscher P, Schlapbach A, Revesz L, Feifel R, Khandoga A, Krombach F, Nelson PJ, Schlöndorff D, Anders HJ.

Am J Pathol. 2007 Apr;170(4):1267-76.


Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.

Vielhauer V, Anders HJ, Schlöndorff D.

Semin Nephrol. 2007 Jan;27(1):81-97. Review.


Expression of the chemokine receptor CCR1 in human renal allografts.

Mayer V, Hudkins KL, Heller F, Schmid H, Kretzler M, Brandt U, Anders HJ, Regele H, Nelson PJ, Alpers CE, Schlöndorff D, Segerer S.

Nephrol Dial Transplant. 2007 Jun;22(6):1720-9. Epub 2007 Feb 13.


The contribution of B cells to renal interstitial inflammation.

Heller F, Lindenmeyer MT, Cohen CD, Brandt U, Draganovici D, Fischereder M, Kretzler M, Anders HJ, Sitter T, Mosberger I, Kerjaschki D, Regele H, Schlöndorff D, Segerer S.

Am J Pathol. 2007 Feb;170(2):457-68.


[Microbial nucleic acids in the pathogenesis of glomerulonephritis].

Anders HJ, Zecher D, Schlöndorff D.

Nephrol Ther. 2006 Dec;2(7):422-31. Epub 2006 Nov 28. English, French.


Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis.

Pawar RD, Patole PS, Ellwart A, Lech M, Segerer S, Schlondorff D, Anders HJ.

J Am Soc Nephrol. 2006 Dec;17(12):3365-73. Epub 2006 Nov 2.


Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy.

Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, Eichinger F, Nitsche A, Kiss E, Bleich M, Gröne HJ, Nelson PJ, Schlöndorff D, Cohen CD, Kretzler M; European Renal cDNA Bank (ERCB) Consortium.

Diabetes. 2006 Nov;55(11):2993-3003.


Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.

Burchardi C, Schlöndorff D.

Nat Clin Pract Nephrol. 2006 Jun;2(6):314-5. No abstract available.


Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept?

Sauter M, Jülg B, Porubsky S, Cohen C, Fischereder M, Sitter T, Schlondorff D, Gröne HJ.

Am J Kidney Dis. 2006 Jun;47(6):1075-80. No abstract available.


Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice.

Ninichuk V, Gross O, Segerer S, Hoffmann R, Radomska E, Buchstaller A, Huss R, Akis N, Schlöndorff D, Anders HJ.

Kidney Int. 2006 Jul;70(1):121-9. Epub 2006 May 24.

Supplemental Content

Loading ...
Support Center